Key points labs should know about the recently proposed OCR rule on privacy protections for PHI associated with reproductive health care.
Diana W. Bianchi, MD, discusses how NIPT has evolved, key challenges, as well as her team’s research on using these tests to detect cancer.
With recent test recalls announced by Universal Medtech and QuidelOrtho, such products now make up one-third of 2023 total recalls listed by the FDA.
Without abortion rights, basic lab testing applications for those who are or want to become pregnant have new and ominous legal implications.
The company has successfully completed clinical trials in Israel on more than 300 women and is applying for CE marking and FDA approval.